| Product Code: ETC7656528 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Multidrug Resistant Bacteria Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Multidrug Resistant Bacteria Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Multidrug Resistant Bacteria Market - Industry Life Cycle |
3.4 Israel Multidrug Resistant Bacteria Market - Porter's Five Forces |
3.5 Israel Multidrug Resistant Bacteria Market Revenues & Volume Share, By Diseases, 2021 & 2031F |
3.6 Israel Multidrug Resistant Bacteria Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
3.7 Israel Multidrug Resistant Bacteria Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.8 Israel Multidrug Resistant Bacteria Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Israel Multidrug Resistant Bacteria Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multidrug-resistant bacteria infections in Israel |
4.2.2 Growing awareness among healthcare providers and patients about the risks associated with multidrug-resistant bacteria |
4.2.3 Rising investments in research and development for new antibiotics and treatment options |
4.3 Market Restraints |
4.3.1 Limited availability of effective antibiotics to combat multidrug-resistant bacteria |
4.3.2 High treatment costs associated with managing infections caused by multidrug-resistant bacteria |
4.3.3 Lack of stringent regulations and policies for antibiotic use and resistance in Israel |
5 Israel Multidrug Resistant Bacteria Market Trends |
6 Israel Multidrug Resistant Bacteria Market, By Types |
6.1 Israel Multidrug Resistant Bacteria Market, By Diseases |
6.1.1 Overview and Analysis |
6.1.2 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By Diseases, 2021- 2031F |
6.1.3 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By Urinary Tract Infection, 2021- 2031F |
6.1.4 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By Intra-Abdominal Infections, 2021- 2031F |
6.1.5 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By Blood Stream Infections, 2021- 2031F |
6.1.6 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By Clostridium Difficile Infections, 2021- 2031F |
6.1.7 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By Acute Bacterial Skin and Skin Structure Infections, 2021- 2031F |
6.1.8 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By Hospital Acquired Bacterial Pneumonia, 2021- 2031F |
6.2 Israel Multidrug Resistant Bacteria Market, By Pathogen |
6.2.1 Overview and Analysis |
6.2.2 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By E. coli, 2021- 2031F |
6.2.3 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By P. Aeruginosa, 2021- 2031F |
6.2.4 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By K. Pneumoniae, 2021- 2031F |
6.2.5 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Multidrug Resistant Bacteria Market, By Drug Class |
6.3.1 Overview and Analysis |
6.3.2 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.3.3 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By Lipoglycopeptides, 2021- 2031F |
6.3.4 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.3.5 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.3.6 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By Combination Therapies, 2021- 2031F |
6.3.7 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Multidrug Resistant Bacteria Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 Israel Multidrug Resistant Bacteria Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Multidrug Resistant Bacteria Market Import-Export Trade Statistics |
7.1 Israel Multidrug Resistant Bacteria Market Export to Major Countries |
7.2 Israel Multidrug Resistant Bacteria Market Imports from Major Countries |
8 Israel Multidrug Resistant Bacteria Market Key Performance Indicators |
8.1 Percentage increase in funding for research and development of new antibiotics and treatment options |
8.2 Number of reported cases of multidrug-resistant bacteria infections in Israel |
8.3 Rate of adoption of infection prevention and control measures in healthcare facilities |
9 Israel Multidrug Resistant Bacteria Market - Opportunity Assessment |
9.1 Israel Multidrug Resistant Bacteria Market Opportunity Assessment, By Diseases, 2021 & 2031F |
9.2 Israel Multidrug Resistant Bacteria Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
9.3 Israel Multidrug Resistant Bacteria Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.4 Israel Multidrug Resistant Bacteria Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Israel Multidrug Resistant Bacteria Market - Competitive Landscape |
10.1 Israel Multidrug Resistant Bacteria Market Revenue Share, By Companies, 2024 |
10.2 Israel Multidrug Resistant Bacteria Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here